Your browser doesn't support javascript.
loading
Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells.
Feng, Jia; Xu, Haichan; Cinquina, Andrew; Wu, Zehua; Chen, Qi; Zhang, Ping; Wang, Xingen; Shan, Huiming; Xu, Lei; Zhang, Qian; Sun, Lihua; Zhang, Wenli; Pinz, Kevin G; Wada, Masayuki; Jiang, Xun; Hanes, William M; Ma, Yupo; Zhang, Hongyu.
Afiliação
  • Feng J; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Xu H; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Cinquina A; iCell Gene Therapeutics LLC Research & Development Division Long Island High Technology Incubator, 25 Health Sciences Drive, Stony Brook, NY, 11790, USA.
  • Wu Z; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Chen Q; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Zhang P; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Wang X; Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Shan H; Department of Radiology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Xu L; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Zhang Q; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Sun L; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Zhang W; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.
  • Pinz KG; iCell Gene Therapeutics LLC Research & Development Division Long Island High Technology Incubator, 25 Health Sciences Drive, Stony Brook, NY, 11790, USA.
  • Wada M; iCell Gene Therapeutics LLC Research & Development Division Long Island High Technology Incubator, 25 Health Sciences Drive, Stony Brook, NY, 11790, USA.
  • Jiang X; iCell Gene Therapeutics LLC Research & Development Division Long Island High Technology Incubator, 25 Health Sciences Drive, Stony Brook, NY, 11790, USA.
  • Hanes WM; iCell Gene Therapeutics LLC Research & Development Division Long Island High Technology Incubator, 25 Health Sciences Drive, Stony Brook, NY, 11790, USA.
  • Ma Y; iCell Gene Therapeutics LLC Research & Development Division Long Island High Technology Incubator, 25 Health Sciences Drive, Stony Brook, NY, 11790, USA. yupo.ma@icellgene.com.
  • Zhang H; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China. zyiqu@outlook.com.
Stem Cell Rev Rep ; 17(2): 652-661, 2021 04.
Article em En | MEDLINE | ID: mdl-33410096
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunoterapia Adotiva / Interleucina-15 / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Imunoterapia Adotiva / Interleucina-15 / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article